Abstract:Context - MicroRNAs (miRNAs) represent a class of small non-coding RNAs that regulate the gene expressions at the posttranscriptional level, subsequently control crucial physiological processes. Recent evidence demonstrates that some miRNAs have the functions similar to oncogene or tumor suppressors, It may play important roles in tumorigenesis MiRNA expression profiles may become useful biomarkers for cancer diagnostics, prognosis and prediction of response to treatment, and it could be a powerful tool for cancer prevention and therapeuticsObjective - To explore the global expression profile of miRNAs in non small cell lung cancer (NSCLC) and its potential relevance to clinicopathological characteristics and prognosis.Methods. - LNA microRNA microarrays were utilized to detect miRNA expression levels in eight surgically removed lung carcinoma tissues (La) and their corresponding normal lung tissues (NT) After initial microarray validation by quantitative real-time reverse transcription polymerase chain reaction assays (qRT-PCR), miR-21, miR-143 and miR-181a were selected for further study in another 47 paired LCTs and matched NTs by qRT-PCR using Taqman microRNA assay.Results. - Twenty-seven microRNAs were observed to be deregulated greater than two-fold in LCT compared with NT by microarray. Consistenting with the microarray, the expression level of miR-21 by qRT-PCR was significantly higher in tumor tissues than in adjacent normal tissues (P = 0026); while miR-143 (P = 0.000) and miR-181a (P= 0.000) were downregulated in LCT. Interestingly, among the 47 NSCLC cases, low level expression of miR-143 was significantly correlated with smoking status (P= 0026), high miR-21 expression (hazard ratio, 5993, 95% confidence interval, 2 518-14.264; P= 0.000) and low miR-181a expression (hazard ratio, 0.328, 95% confidence interval 0.142-0 756; P = 0.009) were associated with poor survival, independent of clinical covariates. including TNM staging, lymph note status.Conclusion. - Our data thus indicating the potential of miR-21, miR-143 and miR-181a as a novel diagnostic or prognostic biomarker for NSCLC. Besides, these data will guide further studies of specific microRNAs might become potential targets for therapeutic intervention. (C) 2010 Elsevier Masson SAS All rights reserved.

Decreased<i> miR-940</i> expression can predict a negative prognosis in early-stage nonsmoking female lung adenocarcinoma

Identification of Stage-associated MicroRNAs in Lung Adenocarcinoma Based on Microarray Data

[Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

MicroRNA Expression Profiles Predict Progression and Clinical Outcome in Lung Adenocarcinoma

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Downregulated Mir-1247-5p Associates with Poor Prognosis and Facilitates Tumor Cell Growth Via DVL1/Wnt/β-catenin Signaling in Breast Cancer

Up-regulation of miR-1825 p predicts poor prognosis in patients with lung cancer and associates with tumor cell growth and migration

Up-Regulation Of Mir-182-5p Predicts Poor Prognosis In Patients With Lung Cancer And Associates With Tumor Cell Growth And Migration

Microrna Profiling and Prediction of Recurrence/Relapse-Free Survival in Stage I Lung Cancer

Decreased Mirna-148a is Associated with Lymph Node Metastasis and Poor Clinical Outcomes and Functions As A Suppressor of Tumor Metastasis in Non-Small Cell Lung Cancer

Decreased Expression Of Mir-204 In Plasma Is Associated With A Poor Prognosis In Patients With Non-Small Cell Lung Cancer

MicroRNA biomarkers and their use in evaluating the prognosis of lung cancer

Prognostic Implications of Decreased Microrna-101-3p Expression in Patients with Non-Small Cell Lung Cancer

Mir-550A-5p Functions As a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma

Construction of Risk Model Associated with Prognosis of Lung Adenocarcinoma Based on a Set of Micrornas by Analyzing TCGA Database

Deregulated Expression of Mir-21, Mir-143 and Mir-181A in Non Small Cell Lung Cancer is Related to Clinicopathologic Characteristics or Patient Prognosis

MicroRNA-29c Functions As a Tumor Suppressor by Targeting VEGFA in Lung Adenocarcinoma

A novel microRNA miR-4433a-3p as a potential diagnostic biomarker for lung adenocarcinoma

Prognostic implications for high expression of MiR-25 in lung adenocarcinomas of female non-smokers

Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas